What does CUSIP 004468500 represent in this 13F holders report?

CUSIP 004468500 is the security identifier for ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock in Q2 2026?

109 institutional investors reported ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock for Q2 2026. Use the holders table for investor-level position and value details.

ACHIEVE LIFE SCIENCES, INC. - Common Stock (ACHV)

CUSIP: 004468500

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock
Total 13F shares: 82,472,984
Total 13F value: $538,512,220
Share change: +58,088,729
Put/Call ratio: 4.8%
SEC-reported price per share: $6.53
Number of holders: 109
Value change: +$387,937,293
Number of buys: 79
Number of sells: 30
Shares outstanding: 105,489,890

Security key

004468500

Report period

Q2 2026

Institutions

109

Top holders

ACHV full security history Ownership snapshot Full 13F holder table ACHIEVE LIFE SCIENCES, INC. SEC filings ACHIEVE LIFE SCIENCES, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

TPG GP A, LLC

Disclosed value leader

Logos Global Management LP

Comparable rows

15/15

Latest evidence

30 Jun 2026

13D/G 3/4/5 13F Lead comparable stake: 13% 13D/G row: TPG GP A, LLC Showing 1-6 of 15 holder rows.

Quick read

TPG GP A, LLC leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TPG GP A, LLC's linked filing trail.

Comparable ownership Top 5

TPG GP A, LLC 13%

Logos Global Management LP 10%

venBio Global Strategic Fund V, L.P. 10%

Paradigm Biocapital Advisors LP 9.2%

FRANKLIN RESOURCES INC 8.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
TPG GP A, LLC	13D/G 3/4/5 10%+ Owner 13D/G 3/4/5	13%	$40,440,170 13,755,160 shares	$0	17 Apr 2025
Logos Global Management LP	13D/G 13D/G	10%	$64,284,484 10,538,440 shares	$0	11 May 2026
venBio Global Strategic Fund V, L.P.	13D/G 13D/G	10%	$31,567,712 10,737,317 shares	$0	15 Apr 2026
Paradigm Biocapital Advisors LP	13D/G 13D/G	9.2%	$29,116,913 9,903,712 shares	$0	17 Apr 2026
FRANKLIN RESOURCES INC	13D/G 13F Company 13D/G 13F	8.3%	$57,979,491 8,878,942 shares	+$16,388,276	30 Jun 2026
Frazier Life Sciences Public Fund, L.P.	13D/G 13D/G	6.5%	$19,479,817 6,625,788 shares	$0	17 Apr 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

109

82,472,984

Rows available

109

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2026 holders

109

Holder diff

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %